Therefore, ligand-independent endocytosis of GPR15 provides a basis for developing interventions targeting this receptor in human inflammatory/immune diseases, where GPR15-expressing cells may play pathogenic roles (9–11, 47). This evidence concerns the gene GPR15 and immune system disorder.